HOOKIPA Pharma Inc. (HOOK)
NASDAQ: HOOK · Real-Time Price · USD
2.300
-0.420 (-15.44%)
Nov 21, 2024, 4:00 PM EST - Market closed

HOOKIPA Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Net Income
-43.37-81.58-64.92-75.67-44.08-43.04
Upgrade
Depreciation & Amortization
3.333.553.64.644.153.07
Upgrade
Asset Writedown & Restructuring Costs
12.9412.77----
Upgrade
Stock-Based Compensation
1.572.355.047.648.665.57
Upgrade
Other Operating Activities
0.060.060.161.230.050.05
Upgrade
Change in Accounts Receivable
0.96.18-0.34-1.94-3.58-3.62
Upgrade
Change in Accounts Payable
-2.76.5-20.866.34.2
Upgrade
Change in Unearned Revenue
-33.84-8.2635.511.420.51-4.44
Upgrade
Change in Other Net Operating Assets
-6.160.912.95-4.2-11.35-3.52
Upgrade
Operating Cash Flow
-67.26-57.52-20-66.02-39.34-41.73
Upgrade
Capital Expenditures
-0.61-4.16-5.02-12.58-2.37-2
Upgrade
Investing Cash Flow
-0.61-4.16-5.02-12.58-2.37-2
Upgrade
Long-Term Debt Repaid
--1.75-2.85-0.44-1.42-2.28
Upgrade
Net Debt Issued (Repaid)
-1.14-1.75-2.85-0.44-1.42-2.28
Upgrade
Issuance of Common Stock
21.2549.0445.690.242.6474.76
Upgrade
Other Financing Activities
-0.14-0.15-0.2--0.22-
Upgrade
Financing Cash Flow
19.9765.6772.27-0.2473.42109.75
Upgrade
Foreign Exchange Rate Adjustments
-0.230.09-0.732.57-2.11-1.03
Upgrade
Net Cash Flow
-48.144.0846.53-76.2729.665
Upgrade
Free Cash Flow
-67.88-61.68-25.01-78.6-41.71-43.73
Upgrade
Free Cash Flow Margin
-135.76%-306.44%-175.55%-426.05%-212.98%-366.19%
Upgrade
Free Cash Flow Per Share
-5.55-6.53-3.82-23.94-16.02-24.48
Upgrade
Cash Interest Paid
00.010.030.050.10.06
Upgrade
Cash Income Tax Paid
0.20.400--
Upgrade
Levered Free Cash Flow
-37.79-39.97-31.83-55.19-29.82-30.12
Upgrade
Unlevered Free Cash Flow
-37.76-39.77-31.4-54.63-29.33-29.57
Upgrade
Change in Net Working Capital
12.3-11.57-10.73.286.464.27
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.